Deciphera Pharmaceuticals Inc (NASDAQ:DCPH)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - DCPH

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - DCPH

  • Market Cap$3.439bn
  • SymbolNASDAQ:DCPH
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS24344T1016

Company Profile

Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations are functioned through the region of US.Deciphera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients.

Latest DCPH news

Currently there for this company. Visit our news hub for other news .